Clinical Trial Update: Systematic Treatment After Successful Surgical Treatment for Primary Hyperparathyroidism With Strontium Ranelate [Phase 4]

View source ↗

Summary

This Phase 4 trial update examines the use of strontium ranelate as systemic treatment after surgical management of primary hyperparathyroidism in patients with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperparathyroidism
• Osteopenia
• Osteoporosis

Drugs mentioned

• Strontium ranelate (strontium ranelate)

Snippet

Sponsor: Medical University of Vienna | Conditions: Primary Hyperparathyroidism, Osteopenia | Phase 4 | Status: COMPLETED